⌘K

Login Start Free

Home/Filings/4/0001144204-13-006185

4//SEC Filing

Damaj Bassam 4

Accession 0001144204-13-006185

CIK 0001411879other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 5:14 PM ET

Size

4.7 KB

Accession

0001144204-13-006185

Insider Transaction Report

Form 4

Period: 2013-02-02

INNOVUS PHARMACEUTICALS, INC.INNV

DirectorPresident and CEO10% Owner

Transactions

Purchase
Common Stock
2013-02-02$0.48/sh+250,406$118,993→ 250,406 total

Footnotes (1)

[F1]Private, non-market transaction.

Documents

1 file

4
v334015_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeother

Related Parties

1

filerCIK 0001478733

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 5:14 PM ET
Size: 4.7 KB

View on SEC.gov